BioSpace News Archive

Policy

Affinity Biosensors Receives FDA Clearance for the LifeScale AST System

Affinity Biosensors, a leading innovator in the field of healthcare diagnostics, announces that its groundbreaking LifeScale AST system has received FDA clearance.

April 3, 2024
·
3 min read
Policy

Partner Therapeutics’ Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Partner Therapeutics, Inc. announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device Agency for the inhaled use of Leukine, branded in Japan as Sargmalin, to treat aPAP.

April 3, 2024
·
8 min read
Policy

IASO Bio Announces U.S. FDA Approval of Investigational New Drug Application for BCMA CAR-T Equecabtagene Autoleucel for Generalized Myasthenia Gravis

IASO Biotechnology is pleased to announce that the Investigational New Drug application for its BCMA CAR-T has been approved by the U.S. Food and Drug Administration for use in U.S. clinical trials for generalised myasthenia gravis.

April 3, 2024
·
5 min read
Business

Alpha Cognition Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

Alpha Cognition Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, reported financial results for the fourth quarter and full year ended 2023 and provided a corporate update.

April 3, 2024
·
10 min read